Another Win for BMS and Pfizer’s APIXABAN Patents Posted on 6 October 2022 Another Win for BMS and Pfizer’s APIXABAN Patents Posted on 6 October 2022
New 3-Step Approach For Patentability as outlined by the CIPO and Benjamin Moore Posted on 14 September 2022 New 3-Step Approach For Patentability as outlined by the CIPO and Benjamin Moore Posted on 14 September 2022
Can Grandma’s Secret Recipes be Protected and Monetized? A look into the patentability of recipes Posted on 12 September 2022 Can Grandma’s Secret Recipes be Protected and Monetized? A look into the patentability of recipes Posted on 12 September 2022
How and When can Software be Patented? How IP law principles interact with emerging tech Posted on 6 September 2022 How and When can Software be Patented? How IP law principles interact with emerging tech Posted on 6 September 2022
CALL FOR APPLICATIONS: IP Innovation Clinic Fellows (2022/23 Academic Year) Posted on 25 August 2022 CALL FOR APPLICATIONS: IP Innovation Clinic Fellows (2022/23 Academic Year) Posted on 25 August 2022
Litigation as a Source of Profit? Non-Practicing Entities and Patent Litigation Posted on 24 August 2022 Litigation as a Source of Profit? Non-Practicing Entities and Patent Litigation Posted on 24 August 2022
The Race Between Tech Companies for Patent Ownership in the Development of Immersive Virtual Experiences Posted on 17 August 2022 The Race Between Tech Companies for Patent Ownership in the Development of Immersive Virtual Experiences Posted on 17 August 2022
Federal Court rules in favour of Janssen for its combination therapy patent Posted on 25 July 2022 Federal Court rules in favour of Janssen for its combination therapy patent Posted on 25 July 2022
Prof. David Vaver Presents “Mr. Justice Laddie and his Intellectual Property Cases: Of Millefeuilles and a Fish Called Elvis” Posted on 29 June 2022 Prof. David Vaver Presents “Mr. Justice Laddie and his Intellectual Property Cases: Of Millefeuilles and a Fish Called Elvis” Posted on 29 June 2022
TRIPS COVID-19 Intellectual Property Waiver: Response to Reported Compromise Posted on 15 June 2022 TRIPS COVID-19 Intellectual Property Waiver: Response to Reported Compromise Posted on 15 June 2022
